Segall Bryant & Hamill, LLC Surmodics Inc Transaction History

Segall Bryant & Hamill, LLC

$7.16 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$27.44 - $35.56 $204,839 - $265,455	-7,465 Reduced 1.85%	396,705 $11.6 Million
Q4 2023 Feb 14, 2024	BUY	$28.47 - $38.49 $40,285 - $54,463	1,415 Added 0.35%	404,170 $14.7 Million
Q3 2023 Nov 09, 2023	BUY	$28.28 - $38.36 $647,809 - $878,712	22,907 Added 6.03%	402,755 $12.9 Million
Q2 2023 Aug 11, 2023	BUY	$17.67 - $31.31 $952,625 - $1.69 Million	53,912 Added 16.54%	379,848 $11.9 Million
Q1 2023 May 15, 2023	SELL	$17.13 - $38.52 $63,792 - $143,448	-3,724 Reduced 1.13%	325,936 $7.42 Million
Q4 2022 Feb 14, 2023	BUY	$29.44 - $37.31 $1.02 Million - $1.29 Million	34,516 Added 11.69%	329,660 $11.2 Million
Q3 2022 Nov 14, 2022	BUY	$28.84 - $38.92 $245,284 - $331,014	8,505 Added 2.97%	295,144 $8.97 Million
Q2 2022 Aug 15, 2022	BUY	$33.25 - $45.11 $113,981 - $154,637	3,428 Added 1.21%	286,639 $10.7 Million
Q1 2022 May 13, 2022	BUY	$40.68 - $49.72 $4.95 Million - $6.05 Million	121,614 Added 75.26%	283,211 $12.8 Million
Q4 2021 Feb 14, 2022	BUY	$43.21 - $57.6 $3.95 Million - $5.26 Million	91,300 Added 129.88%	161,597 $7.78 Million
Q3 2021 Nov 03, 2021	BUY	$52.8 - $60.32 $45,249 - $51,694	857 Added 1.23%	70,297 $3.91 Million
Q2 2021 Aug 12, 2021	BUY	$51.29 - $59.15 $221,316 - $255,232	4,315 Added 6.63%	69,440 $3.77 Million
Q1 2021 May 13, 2021	BUY	$42.18 - $56.07 $2.75 Million - $3.65 Million	65,125 New	65,125 $3.65 Million
Q2 2020 Aug 14, 2020	SELL	$31.07 - $44.74 $660,206 - $950,680	-21,249 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$22.46 - $42.24 $2,740 - $5,153	122 Added 0.58%	21,249 $708,000
Q4 2019 Feb 11, 2020	SELL	$39.01 - $47.51 $39,205 - $47,747	-1,005 Reduced 4.54%	21,127 $875,000
Q3 2019 Nov 12, 2019	SELL	$38.66 - $47.41 $4,755 - $5,831	-123 Reduced 0.55%	22,132 $1.01 Million
Q2 2019 Aug 14, 2019	BUY	$38.23 - $47.43 $36,815 - $45,675	963 Added 4.52%	22,255 $0
Q1 2019 May 15, 2019	SELL	$41.26 - $58.35 $32,100 - $45,396	-778 Reduced 3.53%	21,292 $0
Q4 2018 Feb 15, 2019	SELL	$44.93 - $73.38 $201,331 - $328,815	-4,481 Reduced 16.88%	22,070 $1.04 Million
Q3 2018 Nov 14, 2018	SELL	$56.85 - $80.35 $1.8 Million - $2.55 Million	-31,729 Reduced 54.44%	26,551 $0
Q2 2018 Aug 08, 2018	SELL	$35.85 - $57.05 $2.97 Million - $4.73 Million	-82,853 Reduced 58.71%	58,280 $0
Q1 2018 May 16, 2018	SELL	$27.0 - $38.5 $9,180 - $13,090	-340 Reduced 0.24%	141,133 $0
Q4 2017 Feb 15, 2018	BUY	$28.0 - $33.2 $389,424 - $461,745	13,908 Added 10.9%	141,473 $0
Q3 2017 Nov 14, 2017	BUY	$24.5 - $31.1 $3.13 Million - $3.97 Million	127,565	127,565 $0

Others Institutions Holding SRDX

# of Institutions

126

Shares Held

11.7M

Call Options Held

1.4K

Put Options Held

8.6K

Black Rock Inc. New York, NY

1.17M
Shares

$44.6 Million
0.0% of portfolio
Alliancebernstein L.P. New York, NY

1.04M
Shares

$39.6 Million
0.01% of portfolio
Beryl Capital Management LLC Redondo Beach, CA

989K
Shares

$37.7 Million
14.09% of portfolio
Vanguard Group Inc Valley Forge, PA

804K
Shares

$30.6 Million
0.0% of portfolio
Morgan Stanley New York, NY

753K
Shares

$28.7 Million
0.0% of portfolio

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $533M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Account